Real-World Clinical and Safety Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients
Objective: Here, we evaluate on-going registry outcomes derived from patients implanted with directional Deep Brain Stimulation systems with Multiple Independent Current Control (MICC) technology for…Deep brain stimulation Intraoperative imaging: False errors in the era of artificial intelligence
Objective: To assess the precision of Deep Brain Stimulation (DBS) electrode placement within Subthalamic nucleus (STN) using Advanced Imaging and artificial intelligence, considering the challenges…Understanding the Neurochemical Basis of STN and GPi-DBS: A Human Microdialysis Study
Objective: Analyze the extracellular concentrations of GABA and glutamate in response to acute electrical stimulation during DBS surgery using samples obtained from STN, thalamus, GPi…Time To Access Deep Brain Stimulation Surgery for Movement Disorders: A Canadian Single Center Study
Objective: To assess barriers to accessing Deep Brain Stimulation (DBS), as a function of the time required for each step of the workup and how…The Role of a Social Worker in a Deep Brain Stimulation Multidisciplinary Team
Objective: To characterize the contribution of a social worker (SW) in selecting and managing patients for deep brain stimulation (DBS) surgery. Background: It is common…Early Outcomes Support use of a Remote Cross-Border Surgical Centre for Deep Brain Stimulation in Parkinson’s Disease
Objective: We describe the results of a unique cross border collaboration to deliver BDS for Parkinson's disease in Ireland. Background: Deep brain stimulation (DBS) of…Deep Brain Stimulation during pregnancy: A systematic review of the literature
Objective: We conducted a critical appraisal of the literature on pregnant patients using deep brain stimulation (DBS) in order to assess safety outcomes for maternal…Model-Based Gait Outcomes to Track Parkinson’s Disease Progression ?
Objective: To determine whether outcomes extracted from a gait model can serve as markers of symptoms and neurodegeneration progression in Parkinson’s disease (PD). Background: Longitudinal…Speech Biomarkers for Dysarthria in Parkinson’s Disease — Clinical Validation Across two Languages
Objective: To identify reliable speech biomarkers for assessing dysarthria in individuals with Parkinson's disease (PD) and ensuring their clinical validity across languages. Background: This study…Physical activity in patients with atypical parkinsonian syndromes – Collection of real-world data
Objective: To record mobility in everyday life of patients with MSA, PSP and IPD using sensor-technology over several days. Background: Even in the early disease…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.